Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia

Effects of pemafibrate (K-877) on cholesterol efflux capacity and postprandial hyperlipidemia in patients with atherogenic dyslipidemia

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Journal of Clinical Lipidology - Volume 12, Issue 5, September–October 2018, Pages 1267-1279.e4

Shizuya MD, PhD, Hidenori MD, PhD, Koutaro MD, PhD, Eiichi MD, PhD, Hideki PhD, Shun MD, PhD, K-877 Study Group K-877 Study Group,